Status:
COMPLETED
Sepsis-Associated Purpura Fulminans International Registry - Europe
Lead Sponsor:
Jena University Hospital
Collaborating Sponsors:
Ludwig-Maximilians - University of Munich
Medical University of Vienna
Conditions:
Sepsis
Eligibility:
All Genders
Brief Summary
Sepsis-associated Purpura fulminans (SAPF) is a rare life-threatening condition. It is characterized by multiple skin lesions which rapidly progress to necrosis and gangrene. SAPF is a manifestation o...
Detailed Description
Purpura fulminans is the clinical manifestation of disseminated thrombosis in dermal and systemic microcirculation. This rare disease is frequently associated with multiple organ failure and represent...
Eligibility Criteria
Inclusion
- Diagnosis of sepsis and Purpura fulminans
- Signed informed consent
Exclusion
- Premature neonates (below gestational age of 36 weeks)
Key Trial Info
Start Date :
April 1 2016
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 30 2020
Estimated Enrollment :
28 Patients enrolled
Trial Details
Trial ID
NCT02238795
Start Date
April 1 2016
End Date
September 30 2020
Last Update
May 21 2025
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Jena, Klinik für Anästhesiologie und Intensivmedizin
Jena, Germany
2
University Hospital Jena, Klinik für Kinder- und Jugendmedizin
Jena, Germany
3
Klinikum der Universität München
Munich, Germany, 80337